Stay updated on CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.

Latest updates to the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page
- Check4 days agoChange DetectedThe page content appears unchanged; there are no additions or deletions affecting the study details, eligibility criteria, or outcomes.SummaryDifference0.4%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedMajor change: version updated to v3.2.0 with a government-operational status notice; previous version v3.1.0 was removed.SummaryDifference3%

- Check40 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2. The 'Back to Top' control was removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has been updated to include specific facility information and a detailed clinical study related to Crohn's disease, while removing some redundant location terms and previous disease references.SummaryDifference4%

Stay in the know with updates to CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SubQ in IBD: Pharmacokinetics, Efficacy, Safety Clinical Trial page.